Graham Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$195K	Sell	71,062 -90,495	-56%	-$286K	0.01%	958
2025 Q4	$598K	Buy	161,557 +146,443	+969%	+$473K	0.02%	564
2025 Q3	$40.1K	Buy	+15,114	New	+$29.2K	﹤0.01%	1198
2025 Q2	–	Sell	-487,735	Closed	-$702K	–	1382
2025 Q1	$702K	Buy	487,735 +295,320	+153%	+$544K	0.02%	664
2024 Q4	$423K	Sell	192,415 -45,148	-19%	-$105K	0.01%	804
2024 Q3	$392K	Sell	237,563 -104,327	-31%	-$211K	0.01%	706
2024 Q2	$759K	Buy	+341,890	New	+$804K	0.03%	471
2024 Q1	–	Sell	-41,733	Closed	-$125K	–	1140
2023 Q4	$125K	Sell	41,733 -116,014	-74%	-$150K	﹤0.01%	897
2023 Q3	$155K	Buy	+157,747	New	+$228K	﹤0.01%	896
2023 Q2	–	Sell	-1,031,068	Closed	-$1.64M	–	1057
2023 Q1	$1.64M	Buy	1,031,068 +409,894	+66%	+$2.12M	0.06%	317
2022 Q4	$3.87M	Buy	+621,174	New	+$4.44M	0.15%	94